![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Profile
General Information
Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been approved for obesity management. Xenical acts by inhibiting the absorption of dietary fats.
Approval Date: 1999-04-01
Company Name: Roche
Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been approved for obesity management. Xenical acts by inhibiting the absorption of dietary fats.